市場調査レポート
商品コード
1073954
注入型ドラッグデリバリーの世界市場規模:タイプ別、用法別、流通チャネル別、地域別の予測(2022年~2028年)Global Injectable Drug Delivery Market Size study, by Type, by Usage, by Distribution Channel and Regional Forecasts 2022-2028 |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
注入型ドラッグデリバリーの世界市場規模:タイプ別、用法別、流通チャネル別、地域別の予測(2022年~2028年) |
出版日: 2022年05月06日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文
納期: 2~3営業日
|
世界の注入型ドラッグデリバリーの市場規模は、2021年に約6,245億米ドルと評価され、予測期間である2022年~2028年には11.50%以上の健全な成長率で拡大すると予想されています。
自己注射器に対する需要の高まり、バイオ医薬品市場の拡大、慢性疾患の有病率増加などが、予測期間にわたる注入型ドラッグデリバリーの採用を促進すると予測されています。また、技術的進歩の向上、バイオシミラーやジェネリック注射剤の需要増、製造施設の拡大が、同市場全体の成長を後押しする可能性が高いです。
しかし、代替投与経路の存在、針刺し事故による感染リスク、製品リコールなどが、2021年~2028年の予測期間における市場拡大を阻害する可能性があります。
当レポートでは、世界の注入型ドラッグデリバリー市場を調査し、市場の概要、業界分析、COVID-19によるリスク評価、タイプ・用法・流通チャネル・地域別の分析、および競合情報などを提供しています。
List of figures
Global Injectable Drug Delivery Market is valued at approximately USD 624.5 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 11.50 % over the forecast period 2022-2028. Injectable Drug Delivery is drug delivery system that can be used instead of oral route of administration and is more effective due to its speed of action. Injectable medications are injected directly into the bloodstream using a syringe. As injectable drug delivery provides a vast surface area for absorption, it produces rapid systemic levels of absorption. Rise in demand for self-injectable devices, expanding biologics market and rising prevalence of chronic diseases have driven the adoption of Injectable Drug Delivery across the projected period. For Instance:Chronic diseases afflicted a major share of the Chinese population in 2020. More over 500 million people were overweight or obese, and more than 400 million people suffered from excessive blood pressure. Chronic diseases accounted for 88.5 percent of all fatalities in China in 2019. Also, rising technological advancements, rise in demand for Biosimilar and generic injectable and expanding manufacturing facilities are most likely to boost the overall growth of the Injectable Drug Delivery market. However, presence of alternative routes of administration, risk of infections with needlestick injuries and product recalls can obstruct the market's expansion over the projection period of 2021-2027.
The key regions considered for the global Injectable Drug Delivery market study include Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading region across the world. Rising prevalence of chronic diseases and growing biologics market are driving the market growth in North America. Whereas, Asia Pacific is also anticipated to exhibit the highest growth rate over the forecast period 2021-2027. The market is expected to grow during the projected period, due to rising disposable income and growing partnerships among key players.
Major market players included in this report are:
Amgen Inc.
Antares Pharma Inc.
Becton Dickinson & Company
Consort Medical Plc
Crossjet Ltd
Medtronic Plc
Mylan N. V.
SHL Group
West Pharmaceutical Services
Ypsomed India Pvt. Ltd.
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Type:
Self-Injectors
Needle-Free-Injectors
Auto-Injectors
By Usage:
Disposable Injectors
Reusable Injectors
By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
E-commerce
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year - 2018, 2019, 2020
Base year - 2021
Forecast period - 2022 to 2028
Target Audience of the Global Injectable Drug Delivery Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
11.1 Research Process
11.2 Research Attributes
11.3 Research Assumption